Article
Evaluation of the effects of AZD3480 on cardiac repolarization: a thorough QT/QTc study using moxifloxacin as a positive control.
Clinical pharmacology and therapeutics - 1 Oct 2010
Dalén P, Vik T, Alverlind S, Jostell K-G, Hårdemark H-G
Abstract excerpt
In order to evaluate their potential effects on cardiac repolarization, all new drugs must undergo clinical electrocardiographic evaluation in a thorough QT/QTc (TQT) study. AZD3480, a central nervous system-selective, neuronal nicotinic receptor (NNR) agonist, is predominantly metabolized by cytochrome P450 2D6 (CYP2D6). Employing an innovative design, this TQT study assessed the effects of supratherapeutic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
